GW-M1

General Information


DRACP ID  DRACP02081

Peptide Name   GW-M1

Sequence  GANAAKKLATFAKKIFTAYW

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
AGS Gastric adenocarcinoma Carcinoma IC50=46 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  NIH 3T3: IC50>500 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02081

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C106H162N26O25

Absent amino acids  CDEHMPQRSV

Common amino acids  A

Mass  253971

Pl  10.87

Basic residues  4

Acidic residues  0

Hydrophobic residues  11

Net charge  4

Boman Index  -419

Hydrophobicity  8

Aliphatic Index  69

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  6990

Absorbance 280nm  367.89

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25380626

Title  Antimicrobial peptide GW-H1-induced apoptosis of human gastric cancer AGS cell line is enhanced by suppression of autophagy

Doi 10.1007/s11010-014-2264-3

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.